
We invite you to take a journey with us. A journey begun with daring individual tenacity and shaped by remarkable collective accomplishments. A journey peppered with hardships and decorated with soaring successes. A journey from a two-person enterprise to one of the greatest companies in the world.
It’s the story of Parker.
Welcome.


















The U.S. Food and Drug Administration (FDA) gives Parker clearance to market and sell the Indego® exoskeleton for clinical and personal use in the United States. Indego is a robotic exoskeleton or powered orthotic device that allows users to stand and walk and holds great promise for affording people with paraplegia a new level of independence.
The FDA’s clearance came following the completion of the largest exoskeleton clinical trial conducted to date in the U.S.